ADAM HETZ: Open Payments
NPI 1205107422 · BLAINE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$54,789 in 117 payments from 14 companies in 2025. Trend: 2023 $32,931 · 2024 $40,728 · 2025 $54,789
Speaker / faculty: $46,398Travel & lodging: $5,005Food & beverage: $1,791Consulting: $1,595
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 50 | $29,513 |
| GENZYME CORPORATION | 24 | $13,150 |
| Janssen Biotech, Inc. | 12 | $6,765 |
| Regeneron Healthcare Solutions, Inc. | 21 | $3,604 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,595 |
| Surgenex LLC | 1 | $28 |
| LEO Pharma Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Organon LLC | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SurGraft, ADBRY, Zoryve, EBGLYSS, Odomzo.
Industry payments across MN — which companies pay providers there.
